Skip to main content
. 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171

Table 2.

Fully adjusted HR of risk factors for all-cause mortality according to the presence of NAFLD (multiple-imputation analysis).

Covariate Individuals with NAFLD
Individuals without NAFLD
HR (95% CI) p value HR (95% CI) p value
Sarcopenia 1.78 (1.16–2.73) 0.0089 1.69 (1.19–2.40) 0.0032
Age (years)
 20–39 Reference Reference
 40–59 0.40 (0.23–0.72) 0.0021 0.36 (0.22–0.58) <0.0001
 >60 1.50 (1.07–2.09) 0.0174 1.35 (0.93–1.97) 0.1112
Male 2.11 (1.43–3.10) 0.0001 2.04 (1.56–2.67) <0.0001
Race
 Non-Hispanic White Reference Reference
 Non-Hispanic Black 1.14 (0.72–1.81) 0.569 1.02 (0.76–1.37) 0.9115
 Hispanic 0.73 (0.48–1.09) 0.1215 0.72 (0.49–1.07) 0.1040
 Other race 0.60 (0.18–2.03) 0.4163 0.61 (0.30–1.22) 0.1590
Low income 1.08 (0.74–1.58) 0.689 1.38 (1.15–1.66) 0.0006
College 0.63 (0.41–0.99) 0.0436 0.67 (0.47–0.95) 0.0255
Height (cm) 0.98 (0.96–1.00) 0.1044 0.97 (0.95–0.98) 0.0005
Physical inactivity 1.19 (0.83–1.71) 0.3459 1.13 (0.88–1.45) 0.3272
Active smoker 1.48 (0.93–2.34) 0.0983 1.07 (0.81–1.42) 0.6344
Hypertension 2.10 (1.37–3.23) 0.0007 2.59 (1.84–3.67) <0.0001
Hyperlipidaemia 0.75 (0.51–1.10) 0.1379 1.26 (0.96–1.65) 0.1019
Diabetes 2.23 (1.57–3.15) <0.0001 1.68 (1.14–2.46) 0.0082
History of cancer 2.91 (2.25–3.76) <0.0001 3.02 (2.29–3.98) <0.0001
History of CVD 2.31 (1.49–3.60) 0.0002 2.80 (1.93–4.05) <0.0001
History of kidney disease 1.59 (0.82–3.08) 0.1692 2.31 (1.54–3.48) <0.0001

CVD, cardiovascular disease; HR, hazard ratio; NAFLD, non-alcoholic fatty liver disease.